An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor

Journal of Virology

Volumn 74, Issue 7, 2000, Pages 3321-3329

  Blond, Jean Luc ^a   Lavillette, Dimitri ^a   Cheynet, Valérie ^a   Bouton, Olivier ^a   Oriol, Guy ^a   Chapel Fernandes, Sylvie ^a   Mandrand, Bernard ^a   Mallet, François ^a   Cosset, François Loïc ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; VIRUS RECEPTOR; VIRUS RNA;

ARTICLE; CELL FUSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; OPEN READING FRAME; PLACENTA; PLACENTA FUNCTION; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROVIRUS; RNA ANALYSIS;

CELL FUSION; CELL LINE; ENDOGENOUS RETROVIRUSES; GLYCOPROTEINS; HUMANS; PLACENTA; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0034053834     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.7.3321-3329.2000     Document Type: Article

References (63)

1. Andersen, K. B. 1994. A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion system. J. Virol. 68:3175-3182.
2. Bateman, A., F. Bullough, S. Murphy, L. Emiliusen, D. Lavillette, F.-L. Cosset, R. Cattaneo, S. J. Russell, and R. Vile. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumour growth. Cancer Res., in press.
3. Berlioz-Torrent, C., B. L. Shacklett, L. Erdtmann, L. Delamarre, I. Bouchaert, P. Sonigo, M. C. Dokhelar, and R. Benarous. 1999. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins. J. Virol. 73:1350-1361.
4. Blond, J.-L., F. Besème, L. Duret, O. Bouton, F. Bedin, H. Perron, B. Mandrand, and F. Mallet. 1999. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J. Virol. 73:1175-1185.
5. Boeke, J. D., and J. P. Stoye. 1997. Retrotransposons, endogenous retroviruses, and the evolution of retroelements, p. 343-435. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
6. Boller, K., H. Konig, M. Sauter, N. Mueller-Lantzsch, R. Lower, J. Lower, and R. Kurth. 1993. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology 196:349-353.
7. Boyd, M. T., C. M. R. Bax, B. E. Bax, D. L. Bloxam, and R. A. Weiss. 1993. The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology 196:905-909.
8. Brody, B. A., S. S. Rhee, and E. Hunter. 1994. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J. Virol. 68:4620-4627.
9. Cheynet, V., B. Verrier, and F. Mallet. 1993. Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification. Protein Expr. Purif. 4:367-372.
10. Cohen, M., M. Powers, C. O'Connell, and N. Kato. 1985. The nucleotide sequence of the env gene from the human provirus ERV3 and isolation and characterisation of an ERV3-specific cDNA. Virology 147:449-458.
11. Collawn, J. F., A. Lai, D. Domingo, M. Fitch, S. Hatton, and I. S. Trowbridge. 1993. YTRF is the conserved internalization signal of the transferrin receptor, and a second YTRF signal at position 31-34 enhances endocytosis. J. Biol. Chem. 268:21686-21692.
12. Cosset, F.-L., F. J. Morling, Y. Takeuchi, R. A. Weiss, M. K. L. Collins, and S. J. Russell. 1995. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69:6314-6322.
13. Cosset, F.-L., C. Ronfort, R.-M. Molina, F. Flamant, A. Drynda, M. Benchaibi, S. Valsesia, V.-M. Nigon, and G. Verdier. 1992. Packaging cells for avian leukosis virus-based vectors with various host ranges. J. Virol. 66:5671-5676.
14. Cosset, F.-L., Y. Takeuchi, J.-L. Battini, R. A. Weiss, and M. K. L. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
15. Delamarre, L., C. Pique, A. R. Rosenberg, V. Blot, M.-P. Grange, I. Le Blanc, and M.-C. Dokhelar. 1999. The Y-S-L-I tyrosine-based motif in the cytoplasmic domain of the human T-cell leukemia virus type 1 envelope is essential for cell-to-cell transmission. J. Virol. 73:9659-9663.
16. Denesvre, C., C. Carrington, A. Corbin, Y. Takeuchi, F.-L. Cosset, T. Schulz, M. Sitbon, and P. Sonigo. 1996. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J. Virol. 70:4380-4386.
17. de Parseval, N., and T. Heidmann. 1998. Physiological knockout of the envelope gene of the single-copy ERV-3 human endogenous retrovirus in a fraction of the Caucasian population. J. Virol. 72:3442-3445.
18. Emi, N., T. Friedmann, and J.-K. Yee. 1991. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65:1202-1207.
19. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual, 1st ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
20. Hatziioannou, T., S. J. Russell, and F.-L. Cosset. 2000. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins. Virology 267:49-57.
21. Hatziioannou, T., S. Valsesia-Wittmann, S. J. Russell, and F.-L. Cosset. 1998. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. J. Virol. 72:5313-5317.
22. Hunter, E., and R. Swanstrom. 1990. Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157:187-253.
23. Komurian-Pradel, F., G. Paranhos-Baccala, F. Bedin, A. Ounanian-Paraz, M. Sodoyer, C. Ott, A. Rajoharison, E. Garcia, F. Mallet, B. Mandrand, and H. Perron. 1999. Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 260: 1-9.
24. Kozak, S. L., D. C. Siess, M. P. Kavanaugh, A. D. Miller, and D. Kabat, 1995. The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J. Virol. 69:3433-3440.
25. Landau, N. R., and D. R. Littman. 1992. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66: 5110-5113.
26. Larsson, E., and G. Andersson. 1998. Beneficial role of human endogenous retroviruses: facts and hypotheses. Scand. J. Immunol. 48:329-338.
27. Lavillette, D., M. Maurice, C. Roche, S. J. Russell, M. Sitbon, and F.-L. Cosset. 1998. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J. Virol. 72:9955-9965.
28. Lin, L., and N. S. Rote. 1999. Expression of endogenous retrovirus ERV-3 induces differentiation in BeWo, a choriocarcinoma model of human placental trophoblast. Placenta 20:109-118.
29. Lindemann, D., M. Bock, M. Schweizer, and A. Rethwilm. 1997. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:4815-4820.
30. Löwer. R. 1999. The pathogenic potential of endogenous retroviruses: facts and fantasies. Trends Microbiol. 7:350-356.
31. Löwer, R., J. Löwer, and R. Kurth. 1996. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl. Acad. Sci. USA 93:5177-5184.
32. Lyden, T. W., P. M. Johnson, J. M. Mwenda, and N. S. Rote. 1994. Ultra-structural characterization of endogenous retroviral particles isolated from normal human placentas. Biol. Reprod. 51:152-157.
33. + cells. J. Virol. 71:3341-3345.
34. Martin, F., S. Neil, J. Kupsch, M. Maurice, F.-L. Cosset, and M. Collins. 1999. Retrovirus targeting by tropism restriction to melanoma cells. J. Virol. 73:6923-6929.
35. Miletic, H., M. Bruns, K. Tsiakas, B. Vogt, R. Rezal, C. Baum, K. Kühlke, F.-L. Cosset, W. Ostertag, H. Lother, and D. von Laer. 1999. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J. Virol. 73: 6114-6116.
36. Miller, D. G., R. H. Edwards, and A. D. Miller. 1994. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc. Natl. Acad. Sci. USA 91:78-82.
37. Miyazono, K., T. Okabe, A. Urabe, F. Takaku, and C. H. Heldin. 1987. Purification and properties of an endothelial cell growth factor from human platelets. J. Biol. Chem. 262:4098-4103.
38. Nelson, J., J. A. Leong, and J. A. Levy. 1978. Normal human placentas contain RNA-directed DNA polymerase activity like that in viruses. Proc. Natl. Acad. Sci. USA 75:6263-6267.
39. O'Hara, B., S. V. Johann, H. P. Klinger, D. G. Blair, H. Rubinson, K. J. Dunn, P. Sass, S. M. Vitek, and T. Robbins. 1990. Characterisation of the human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth Differ. 1:119-127.
40. Park, B. H., B. Matuschke, E. Lavi, and G. N. Gaulton. 1994. A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease. J. Virol. 68:7516-7524.
41. Patience, C., Y. Takeuchi, F.-L. Cosset, and R. A. Weiss. 1998. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells. J. Virol. 72:2671-2676.
42. Patience, C., Y. Takeuchi, and R. A. Weiss. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3:282-286.
43. Porter, C. D., M. K. L. Collins, C. S. Tailor, M. H. Parker, F.-L. Cosset, R. A. Weiss, and Y. Takeuchi. 1996. Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. Hum. Gene Ther. 7:913-919.
44. Ragheb, J. A., and W. F. Anderson. 1994. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68:3220-3231.
45. Rasko, J. E., J. L. Battini, R. J. Gottschalk, I. Mazo, and A. D. Miller. 1999. The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc. Natl. Acad. Sci. USA 96:2129-2134.
46. Rein, A., J. Mirro, J. G. Haynes, S. M. Ernst, and K. Nagashima. 1994. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68:1773-1781.
47. Schnierle, B. S., J. Stitz, V. Bosch, F. Nocken, H. Merget-Millitzer, M. Engelstadter, R. Kurth, B. Groner, and K. Cichutek. 1997. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HlV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. USA 94:8640-8645.
48. Seifarth, W., H. Skladny, F. Krieg-Schneider, A. Reichert, R. Hehlmann, and C. Leib-Mösch. 1995. Retrovirus-like particles released from the human breast cancer cell line T47-D display type B-and C-related endogenous retroviral sequences. J. Virol. 69:6408-6416.
49. Sommerfelt, M. A. 1999. Retrovirus receptors. J. Gen. Virol. 80:3049-3064.
50. Sommerfelt, M. A., and R. A. Weiss. 1990. Receptor interference groups of 20 retroviruses plating on human cells. Virology 176:58-69.
51. Spiegel, M., M. Bitzer, A. Schenk, H. Rossmann, W. J. Neubert, U. Seidler, M. Gregor, and U. Lauer. 1998. Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J. Virol. 72:5296-5302.
52. Suomalainen, M., and H. Garoff. 1994. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J. Virol. 68:4879-4889.
53. Tailor, C. S., A. Nouri, Y. Zhao, Y. Takeuchi, and D. Kabat. 1999. A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J. Virol. 73:4470-4474.
54. Takeuchi, Y., F.-L. Cosset, P. J. Lachmann, H. Okada, R. A. Weiss, and M, K. L. Collins. 1994. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68:8001-8007.
55. van Zeijl, M., S. V. Johann, E. Closs, J. Cunningham, R. Eddy, T. B. Shows, and B. O'Hara. 1994. An amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc. Natl. Acad. Sci. USA 91:1168-1172.
56. Venables, P. J., S. M. Brookes, D. Griffiths, R. A. Weiss, and M. T. Boyd. 1995. Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology 211:589-592.
57. Voisset, C., A. Blancher, H. Perron, B. Mandrand, F. Mallet, and G. Paranhos-Baccalà. 1999. Phylogeny of a novel family of human endogenous retrovirus sequences, HERV-W, in humans and different primates. AIDS Res. Hum. Retrovir. 15:1529-1533.
58. Wilkinson, D. A., D. L. Mager, and J.-A. C. Leong. 1994. Endogenous human retroviruses, p. 465-534. In J. A. Levy (ed.), The Retroviridae, vol. 3. Plenum Press, New York, N.Y.
59. Wool-Lewis, R. J., and P. Bates. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72:3155-3160.
60. Yang, C., and R. W. Compans. 1996. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide. J. Virol. 70:248-254.
61. Yang, C., and R. W. Compans. 1997. Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity. J. Virol. 71:8490-8496.
62. Yee, J. K., T. Friedmann, and J. C. Burns. 1994. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43:99-112.
63. Zavorotinskaya, T., and L. M. Albritton. 1999. Failure to cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction. J. Virol. 73:5621-5629.